{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013632","form_type":"8-K","ticker":"NRXS","cik":"0001933567","company_name":"Neuraxis, INC","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.500382+00:00","generated_at":"2026-05-20T00:22:30.492310+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Neuraxis stockholders approve Series B conversion stock issuance; elect directors","bullets":["Votes to approve issuance of 20%+ of outstanding common stock upon conversion of Series B Preferred Stock passed with 4.1M for, 129K against, 1.1M broker non-votes.","All six director nominees elected: Brian Carrico, Dr. Christopher R Brown, Bradley Mitch Watkins, Beth Keyser, Kristen Ferge, Dr. Gilad Aharon.","Ratification of auditor Rosenberg Rich Baker Berman, P.A. approved with 5.66M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013632","json":"https://secwatch.observer/filing/0001641172-25-013632.json","markdown":"https://secwatch.observer/filing/0001641172-25-013632.md","text":"https://secwatch.observer/filing/0001641172-25-013632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1933567/000164117225013632/0001641172-25-013632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1933567/000164117225013632/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T00:22:30.492310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}